Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GVK Biosciences (GVK BIO), a contract research organization, has entered into a licensing agreement with the Division of Cancer Prevention (DCP), National Cancer Institute (NCI), for GVK BIO Online Biomarker Database (GOBIOM).
Subscribe to our email newsletter
The GOBIOM is a collection of 15,500 clinically evaluated, exploratory and preclinical biomarkers associated with diverse therapeutic areas reported in global clinical trials, clinical and preclinical studies.
GVK BIO Informatics sales and marketing vice president Sreeni Devidas said that the DCP chose the GVK BIO Biomarker Database for its research efforts.
"It is a clear testimony to the quality, content and utility of the database," Devidas added.
"The coverage in Oncology will enable researchers at the DCP to accelerate their discovery efforts."
GOBIOM contains information on biochemical, genomic, imaging, metabolite, cellular and physiological markers.
The database contains several data points covering experimental, analytical, clinical, preclinical and statistical data with their qualifications under different medical interventions, according to GVK.
GOBIOM, which covers over 100 different ethnicities, provides information on approved assay methodologies and companion diagnostics.